Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179439 · ClinicalTrials.gov registry record
NPDT Evaluation in Children With CFTR and (PSC)
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 50
- Enrollment target
NCT00179439 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 50 participants.
The verdict
NCT00179439 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The investigators hypothesize that PSC in children is associated with mutations and functional changes of the cystic fibrosis (CF) gene.
Interventions
- PROCEDURE nasal potential difference testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2004-01 |
| Est. Completion | 2006-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00179439
The ClinicalTrials.gov registry entry for NCT00179439 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which nasal potential difference testing is the first listed.
NCT00179439 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00179439 about?
NCT00179439 is a clinical study titled "NPDT Evaluation in Children With CFTR and (PSC)". The investigators hypothesize that PSC in children is associated with mutations and functional changes of the cystic fibrosis (CF) gene.
What is the current status of trial NCT00179439?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2004-01. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00179439?
The interventions under investigation include: nasal potential difference testing (PROCEDURE).
Who is sponsoring clinical trial NCT00179439?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.